Open AccessFIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy
Author(s) -
Fernando González-Torralba,
Adolfo Baloira,
Araceli Abad,
Antònia Fuster,
Juan Luis García-Rivero,
Patricia García-Sidro,
Eduardo Márquez-Martín,
Marta Palop,
Néstor Soler,
José Luis Velasco
Publication year - 2022
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s360938
Subject(s) - medicine , copd , inhaler , inhalation , peak flow meter , lung , dry powder inhaler , delphi method , intensive care medicine , anesthesia , asthma , computer science , artificial intelligence
The pharmacological treatment of chronic obstructive pulmonary disease (COPD) is largely based on inhaled bronchodilators. Inspiratory flow and lung deposition are key parameters to be considered in inhaled therapy; however, the relationship between these two parameters, the patient specificities, and the suitability of the inhaler type for COPD management has not been fully addressed. The present study follows a Delphi Panel methodology to find expert consensus on the role of inspiratory flow and lung deposition as key decision factors in COPD inhaled therapy.